Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: A phase I trial
Anna Berkenblita, i, , , Ursula A. Matulonisb, i, Joan F. Kroenerc, Bruce J. Dezubea, i, Gil N. Lamd, Luceli C. Cuasaye, Nils Brünnerf, Terence R. Jonesg, Michael H. Silvermanh and Michael A. Goldj
. Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: A phase I trial
. Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: A phase I trial. 2005; 99(1):50-57.